Israel Englander Relmada Therapeutics, Inc. Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Relmada Therapeutics, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 561,826 shares of RLMD stock, worth $202,257. This represents 0.0% of its overall portfolio holdings.

Number of Shares

561,826

Previous 64,357 772.98%

Holding current value

$202,257

Previous $193,000 843.01%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$2.3 - $4.36 $1.14 Million - $2.17 Million	497,469 Added 772.98%	561,826 $1.82 Million
Q2 2024 Aug 14, 2024	SELL	$2.93 - $4.94 $811,882 - $1.37 Million	-277,093 Reduced 81.15%	64,357 $193,000
Q1 2024 May 15, 2024	BUY	$3.1 - $6.8 $441,901 - $969,333	142,549 Added 71.67%	341,450 $1.59 Million
Q4 2023 Feb 14, 2024	SELL	$2.45 - $4.22 $355,431 - $612,212	-145,074 Reduced 42.18%	198,901 $823,000
Q2 2023 Aug 14, 2023	BUY	$2.22 - $3.54 $314,456 - $501,430	141,647 Added 70.01%	343,975 $846,000
Q1 2023 May 15, 2023	SELL	$2.24 - $4.76 $1.93 Million - $4.09 Million	-859,446 Reduced 80.94%	202,328 $457,000
Q4 2022 Feb 14, 2023	BUY	$2.17 - $35.84 $2.26 Million - $37.3 Million	1,042,044 Added 5281.52%	1,061,774 $3.71 Million
Q3 2022 Nov 14, 2022	SELL	$18.3 - $37.02 $1.81 Million - $3.66 Million	-98,780 Reduced 83.35%	19,730 $730,000
Q2 2022 Aug 15, 2022	SELL	$16.5 - $30.34 $2.66 Million - $4.89 Million	-161,079 Reduced 57.61%	118,510 $2.25 Million
Q1 2022 May 16, 2022	SELL	$16.72 - $26.99 $4.59 Million - $7.41 Million	-274,403 Reduced 49.53%	279,589 $7.55 Million
Q4 2021 Feb 14, 2022	BUY	$16.93 - $26.82 $5.07 Million - $8.03 Million	299,412 Added 117.61%	553,992 $12.5 Million
Q3 2021 Nov 15, 2021	BUY	$21.86 - $34.77 $5.21 Million - $8.29 Million	238,351 Added 1468.67%	254,580 $6.67 Million
Q2 2021 Aug 16, 2021	BUY	$29.55 - $39.15 $291,363 - $386,019	9,860 Added 154.81%	16,229 $519,000
Q1 2021 May 17, 2021	SELL	$31.52 - $39.28 $585,042 - $729,076	-18,561 Reduced 74.45%	6,369 $224,000
Q4 2020 Feb 16, 2021	SELL	$29.88 - $39.8 $549,732 - $732,240	-18,398 Reduced 42.46%	24,930 $800,000
Q2 2020 Aug 14, 2020	BUY	$31.59 - $49.98 $154,948 - $245,151	4,905 Added 12.77%	43,328 $1.94 Million
Q1 2020 May 14, 2020	BUY	$23.78 - $50.12 $361,979 - $762,926	15,222 Added 65.61%	38,423 $1.31 Million
Q4 2019 Feb 14, 2020	BUY	$10.1 - $47.18 $234,330 - $1.09 Million	23,201 New	23,201 $905,000

Others Institutions Holding RLMD

# of Institutions

Shares Held

12.3M

Call Options Held

229K

Put Options Held

138K

View Full List

About RELMADA THERAPEUTICS, INC.

Ticker RLMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,608,500
Market Cap $10.3M
Description
Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...

More about RLMD

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account